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Helium–oxygen mixture does not improve gas exchange in
mechanically ventilated children with bronchiolitis
Matthew F Gross, Robert M Spear and Bradley M Peterson
Children’s Hospital and Health Center, San Diego, California, USA
Statement of findings
Varying concentrations of helium–oxygen (heliox) mixtures were evaluated in mechanically
ventilated children with bronchiolitis. We hypothesized that, with an increase in the
helium:oxygen ratio, and therefore a decrease in gas density, ventilation and oxygenation
would improve in children with bronchiolitis. Ten patients, aged 1–9 months, were
mechanically ventilated in synchronized intermittent mandatory ventilation (SIMV) mode with
the following gas mixtures delivered at 15-min intervals: 50%/50% nitrogen/oxygen,
50%/50% heliox, 60%/40% heliox, 70%/30% heliox, and return to 50%/50% nitrogen/
oxygen. The use of different heliox mixtures compared with 50%/50% nitrogen/oxygen in
mechanically ventilated children with bronchiolitis did not result in a significant or noticeable
decrease in ventilation or oxygenation.
Keywords: bronchiolitis, helium, mechanical ventilation, pediatrics, respiratory failure
Synopsis
Received: 31 January 2000
Revisions requested: 9 March 2000
Revisions received: 21 March 2000
Accepted: 21 March 2000
Published: 13 April 2000
Crit Care 2000, 4:188–192
The electronic version of this article can be found online at
http://ccforum.com/content/4/3/188
© Current Science Ltd
FiO2 = fractional inspired oxygen; heliox = helium–oxygen; PaCO2 = arterial carbon dioxide tension; PACO2 = alveolar carbon dioxide tension;
PaO2 = arterial oxygen tension; SIMV = synchronized intermittent mandatory ventilation.
Introduction: Heliox has been found to reduce both the arterial
carbon dioxide tension (PaCO2) and work of breathing in
children and adults with status asthmaticus. We hypothesized
that, in mechanically ventilated children with bronchiolitis,
increasing the ratio of helium:oxygen concentrations would
improve both ventilation and oxygenation.
Objective: To examine the effect of varying concentrations of
heliox mixtures on ventilation and oxygenation in mechanically
ventilated children with bronchiolitis.
Patients and methods: This was a case series, with a
nonrandomized, unblinded, repeated-measures design, which
was conducted in a pediatric intensive care unit in a
children’s hospital. Ten patients, aged 1–9 months, were
mechanically ventilated in SIMV mode with the following gas
mixtures delivered at 15-min intervals: 50%/50% nitrogen/
oxygen, 50%/50% heliox, 60%/40% heliox, 70%/30% heliox,
and return to 50%/50% nitrogen/oxygen. Two-factor, repeated-
measures analysis of variance was used to determine
whether the different gas mixtures affected the mean PaCO2,
the ratio of arterial oxygen tension (PaO2) to fractional
inspired oxygen (FiO2), or the ratio of PaO2 to alveolar oxygen
tension (PAO2).
Results: No statistical or noticeable difference was found
between the mean PaCO2, PaO2/FiO2, or PaO2/PAO2 values
while the patients were receiving the four different gas
mixtures (P = 0.93, 0.98, and 0.96, respectively).
Conclusion: The use of different heliox mixtures compared
with 50%/50% nitrogen/oxygen in mechanically ventilated
children with bronchiolitis did not result in a significant or




Bronchiolitis is a disease that is epidemic during winter
months worldwide. The pathogen that is most commonly
found to be responsible for this illness is the respiratory
syncytial virus. Each year, up to 2% of all infants in a com-
munity require hospitalization for bronchiolitis due to
feeding difficulty, respiratory distress, apnea, or the need
for supplemental respiratory support. Bronchiolitis in pre-
mature infants, infants less than 3 months of age, children
with chronic lung disease, children with cardiac disease,
and children with severe disease often mandates endotra-
cheal intubation and mechanical ventilation.
Helium gas reduces the work of breathing in obstructive pul-
monary disease and is an effective adjunct in the manage-
ment of status asthmaticus [1–4]. Heliox has been found
[1–4] to reduce both the PaCO2 and work of breathing in
children and adults with status asthmaticus. One recent
study [5] found an improvement in clinical asthma scores in
nonintubated children with bronchiolitis. However, no con-
trolled studies have been published that examined the use of
heliox in conjunction with positive-pressure ventilation in chil-
dren with bronchiolitis. We hypothesized that, in mechani-
cally ventilated children with bronchiolitis, increasing the ratio
of helium:oxygen concentrations would improve both ventila-
tion and oxygenation. To evaluate this hypothesis, we
prospectively assessed the effect of different concentrations
of heliox on PaCO2, PaO2/FiO2, and PaO2/PAO2 in mechan-
ically ventilated children with bronchiolitis.
Patients and methods
Study population
We studied 10 pediatric patients with the diagnosis of
viral bronchiolitis and respiratory failure mandating endo-
tracheal intubation and mechanical ventilation who were
admitted to the Critical Care Unit at Children’s Hospital
and Health Center, San Diego, California, USA. Bronchi-
olitis was defined by either a positive viral pathogen study
or a clinical diagnosis with negative tracheal bacterial
culture at the time of endotracheal intubation. Enrolment
was from November 1996 to April 1998. The study proto-
col was approved by the Institutional Review Board for the
Children’s Hospital, San Diego, California, USA. Informed
written consent was obtained from the patient’s parent(s)
before study enrolment. Enrolment criteria included the fol-
lowing: corrected gestational age greater than 38 weeks
and less than 2 years at time of entry into the study;
patient intubated more than 3 h and less than 48 h at
onset of the study; no administration of brochodilators
within 4 h of the initiation of the study; hemodynamic sta-
bility requiring no blood products or vasoactive medica-
tions before or during the study period; and no underlying
congenital heart disease, chronic pulmonary disease, ter-
minal illness, immune disease, or neuromuscular disease.
Study design
This study was a case series, and was of a nonrandom-
ized, unblinded, repeated-measures design. All patients
were mechanically ventilated using a Servo 900C ventila-
tor (Siemens-Elema, Stockholm, Sweden) in SIMV mode
with a tidal volume of 7–12 ml/kg, positive end-expiratory
pressure of 5 cmH2O, inspiratory time of 0.8–1.0 s (mean
inspiratory:expiratory ratio of 1:2.2), and ventilator rate of
15–30 breaths/min (Table 1). None of these ventilator
parameters were adjusted during the 75 min of the study.
Before the initiation of the study, 50%/50% nitrogen/
oxygen was delivered. All patients were sedated with a
fentanyl infusion and were paralyzed with vecuronium
during the trial. Demographic data collection, review of
chest radiographs, and respiratory examination were per-
formed by the primary clinical investigator before onset of
the trial. Physiologic data collection was performed using
the cardiorespiratory monitor (Marquette Transcope 12C,
GE Medical Systems, Milwaukee, WI, USA) in conjunction
with an arterial catheter for continuous blood pressure and
intermittent blood gas analysis.
No patient had tracheal suctioning within 20 min before or
during the study. The only change made to the respiratory
circuit during the study was to the gas mixture, as defined
below. The different heliox concentrations provided by the
ventilator were obtained by adjusting the relative flow
rates of 100% oxygen to 100% helium gas supplied to the
ventilator until the desired ratio was obtained, which was
determined by measuring the oxygen fraction (55/90
oxygen analyzer, Hudson RCI, Ventronics Division, Temec-
ula, CA, USA) in the inspiratory limb of the ventilator
circuit. The ventilator was calibrated to deliver a constant
tidal volume to each patient on the different gas mixtures.
Protocol required that the trial be terminated in the event
of any pulmonary toilet, other ventilator adjustment, inter-
ruption of the respiratory circuit, or acute deterioration in
patient status requiring other interventions.
Temperature, heart rate, mean arterial blood pressure,
measured oxygen saturation, arterial blood gas, and calcu-
lated PaO2/FiO2 and PaO2/PAO2 ratios were obtained at
study onset and at 15-min intervals, just before changing
the gas mixture. For each patient, data sets were collected
15 min apart while the patient was receiving the following
sequence of gas mixtures: 50%/50% nitrogen/oxygen,
50%/50% nitrogen/oxygen, 50%/50% heliox, 60%/40%
heliox, 70%/30% heliox, and 50%/50% nitrogen/oxygen.
Statistical analysis
Data are presented as mean ± standard deviation for
normal distributions. Statistical analysis was performed
using two-factor, repeated-measures, univariate analysis of
variance to determine whether the different gas mixtures
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resulted in significant change in the mean PaCO2,
PaO2/FiO2, or PaO2/PAO2 values. P < 0.05 was consid-
ered statistically sugnificant.
Results
Ten patients, seven male and three female, with a mean
age of 4±3 months (range 1–9 months), were enroled into
the study. Six patients were positive for respiratory syncy-
tial virus on viral pathogen study. On average, the patients
had upper respiratory symptoms for 2 days and increased
work of breathing for 1 day before intubation. All patients
required mechanical ventilation for respiratory failure as
indicated by refractory tachypnea with fatigue or apnea.
Data presented for 50%/50% nitrogen/oxygen in Tables 1
and 2 are the averages of the initial two baseline
50%/50% nitrogen/oxygen data sets (obtained 15 min
apart) and the final data set (obtained at 75 min from the
onset of the study period) on return to 50%/50% nitro-
gen/oxygen. All patients’ hemodynamic, respiratory status,
and blood gas determinations were stable at the onset
and on return to baseline 50%/50% nitrogen/oxygen at
the end of the study period. There was no statistical or
clinically significant difference between any of these three
data sets on 50%/50% nitrogen/oxygen for an individual
patient. Therefore, any change in ventilation or oxygenation
seen with the different heliox gas mixtures should be the
result of the change in gas mixture.
Changes in ventilation and oxygenation with changes in
gas mixture for the 10 patients studied are presented in
Table 1, with statistical analysis presented in Table 2. No
statistical differences were found between the mean
PaCO2, PaO2/FiO2, or PaO2/PAO2 values while receiving
the four different gas mixtures (P = 0.93, 0.98, 0.96,
respectively).
Table 1
Changes in ventilation and oxygenation with changes in gas mixture in 10 infants with bronchiolitis on mechanical ventilation
Patient
Variable 1 2 3 4 5 6 7 8 9 10
Age (months) 9 1 1 6 4 7 2 1 4 2
RSV positive No No Yes No Yes No Yes Yes Yes Yes
Ventilator rate 20 22 18 15 28 18 15 30 20 25
(breaths/min)
IT (s) 1.0 0.8 0.8 0.8 1.0 1.0 1.0 1.0 1.0 0.8
I:E 1:2 1:2 1:3 1:4 1:1 1:2 1:3 1:1 1:2 1:2
PaCO2 (mmHg)
50/50 Nitrogen/ 45 53 44 40 47 53 65 28 35 40
oxygen
50/50 Heliox 43 53 41 38 46 52 62 28 39 36
60/40 Heliox 34 51 44 39 48 45 65 26 37 38
70/30 Heliox 35 53 44 37 45 41 69 26 34 36
PaO2/FiO2
50/50 Nitrogen/ 183 251 246 193 174 351 395 485 167 225
oxygen
50/50 Heliox 190 284 182 200 232 366 364 450 188 212
60/40 Heliox 245 220 325 200 203 370 330 445 183 230
70/30 Heliox 237 290 303 233 190 313 240 360 213 207
PaO2/PAO2
50/50 Nitrogen/ 0.30 0.42 0.39 0.31 0.28 0.26 0.35 0.58 0.68 0.74
oxygen
50/50 Heliox 0.30 0.47 0.29 0.31 0.37 0.30 0.33 0.60 0.62 0.69
60/40 Heliox 0.39 0.38 0.54 0.33 0.34 0.29 0.37 0.62 0.60 0.69
70/30 Heliox 0.40 0.54 0.54 0.40 0.34 0.36 0.35 0.54 0.50 0.57
I:E, ratio of ventilator inspiratory to expiratory times; IT, ventilator inspiratory time; RSV, respiratory syncytial virus.
All patients who were enroled completed the study, with
no complications or departures from the protocol. Only
three out of the 10 patients were continued on heliox after
the study period at the discretion of the primary care team.
Discussion
In normal conducting airways convective forces dominate,
whereas in small airways diffusive forces dominate. A
sharp gradient exists in the intermediate airways where
these different forces meet, accounting for the majority of
alveolar and inspired gas mixing [3]. This gradient is dimin-
ished when either the airways are narrowed or obstructed,
or both, as in asthma or bronchiolitis.
Reynolds number (Re = ρUd/µ, where ρ is the gas density,
U is the velocity, d is the diameter of the tube, and µ is the
viscosity of the gas) predicts whether flow through a
straight, unbranched tube will be laminar or turbulent.
When the Reynolds number in a straight, unbranched tube
is greater than 1500–2000 units, turbulent flow occurs. In
a branching tube or around an obstructed region, turbu-
lent flow occurs at a lower Reynolds number. Laminar gas
flow through a straight, unbranched tube is described by
the Hagen–Poiseuille equation (∆P = RV = 8Lµ/pir4, where
∆P is the change in pressure, R is the resistance, V is the
gas flow rate, L is the length of the tube, and r is the
radius). When flow of a given gas mixture exceeds a criti-
cal velocity, the flow becomes turbulent and the flow
equation changes to ∆P = V2ρfL/4pi2r5 (where f is frictional
factor). Note that laminar flow is directly dependent on the
gas viscosity µ, whereas turbulent flow is directly depen-
dent on the gas density ρ.
Helium is an inert gas that is insoluble in human tissues
and has no bronchodilatory or anti-inflammatory proper-
ties. Long-term inhalation of heliox mixtures at a pressure
of 1 atmosphere has no discernible deleterious effects [6].
Heliox at 70%/30% has about the same viscosity as
70%/30% nitrogen/oxygen but only one fifth the density,
and thus, when turbulent flow predominates, an increase
in flow will occur with heliox [7]. Helium further lowers
airway resistance by reducing the Reynolds number
approximately fourfold, so that some areas of turbulent
flow are converted to laminar flow [8,9]. Thus, for a given
driving pressure, an overall increase in both inspiratory
and expiratory turbulent and laminar flow should be seen
with helium compared with nitrogen [3]. In addition, with
the same FiO2, helium allows for increased diffusion of
carbon dioxide, via its lower density compared with that of
nitrogen [10]. Thus, the substitution of helium for nitrogen
enhances both convective and diffusive forces, effectively
recruiting low ventilation/perfusion units [3]. In addition,
helium may enhance gas transport through collateral venti-
lation [11].
The effect of airway narrowing caused by bronchiolitis is
much more pronounced with a smaller initial airway. This is
because airway resistance increases exponentially in rela-
tion to a decreasing airway radius, a phenomenon that is
more pronounced in situations where turbulent flow exists
(R ~ 1/r5; where R is the resistance and r is the radius)
compared with laminar flow (R ~ 1/r4). The patient with
bronchiolitis compensates for the marked increase in
airway resistance by increasing both the force of respira-
tion and the respiratory rate to maintain minute ventilation
and gas exchange. This can result in muscle fatigue and
ultimately respiratory failure.
Elleau et al [12] found that infants with respiratory distress
syndrome of prematurity ventilated with heliox required a
lower FiO2, and had a shorter duration of mechanical venti-
lation, lower incidence of bronchopulmonary dysplasia, and
fewer deaths. Hollman et al [5] found in nonintubated chil-
dren with bronchiolitis that the beneficial effects of heliox
were most pronounced in those children with the greatest
degree of respiratory compromise. Also, multiple studies of
patients with status asthmaticus and carbon dioxide reten-
tion have demonstrated that heliox may be beneficial in
reducing PaCO2 and decreasing the degree of respiratory
distress, thus avoiding mechanical ventilation [2–4].
In the present study, a statistically significant reduction in
PaCO2 was not observed with any heliox mixture com-
pared with baseline 50%/50% nitrogen/oxygen (P = 0.93).
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Table 2
Statistical analysis of the changes in ventilation and oxygenation with changes in gas mixture in 10 infants with bronchiolitis who
were on mechanical ventilation
Gas mixture PaCO2 (mmHg) PaO2/FiO2 PaO2/PAO2
50%/50% Nitrogen/oxygen 45 ± 10 267 ± 108 0.43 ± 0.17
50%/50% Heliox 44 ± 10 267 ± 95 0.43 ± 0.15
60%/40% Heliox 43 ± 11 275 ± 87 0.45 ± 0.14
70%/30% Heliox 42 ± 12 259 ± 55 0.45 ± 0.09
Values are expressed as mean ± standard deviation. Two-factor, repeated-measures analysis of variance found no statistically significant difference
between the mean values for PaCO2, PaO2/FiO2, and PaO2/PAO2 for the different gas mixtures (P = 0.93, P = 0.98, and P = 0.96, respectively).
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Only patients 1 and 6 showed a moderate decrease in the
level of PaCO2 (Table 1). Clinically significant carbon
dioxide retention was not problematic in any of the
patients studied, and the level of PaCO2 was easily con-
trolled before the onset of the study by increasing the ven-
tilator rate or tidal volume. Possibly, had we ventilated the
patients in a pressure control mode that allowed for
changes in tidal volumes, a reduction in PaCO2 with heliox
administration might have occurred.
Because of its lower density, helium decreases resistance
to gas flow in turbulent conditions. With all other factors
kept constant, the turbulent gas flow equation for a
straight unbranched tube would predict 70%/30% heliox
to have 2.2 times more flow than 50%/50% nitrogen/
oxygen. No noticeable or statistical change in oxygenation,
as indicated by an increase in PaO2/FiO2 and PaO2/PAO2
ratios, was found. However, there was a modest improve-
ment in both the PaO2/FiO2 and PaO2/PAO2 ratios for
patients 1, 2, 3, and 4 (Table 1).
It is possible that we failed to show a significant improve-
ment in ventilation and oxygenation as a result of one or more
of the following: the small sample size (n=10); the patients
had only mild to moderate lung disease; the mode of ventila-
tion (ie SIMV); and an ineffective concentration of helium.
In conclusion, the use of different heliox mixtures com-
pared with 50%/50% nitrogen/oxygen in mechanically
ventilated children with bronchiolitis did not result in a sta-
tistically significant decrease in PaCO2 or increase in
PaO2/FiO2 or PaO2/PAO2 ratios. Heliox was well tolerated
by all patients, and no adverse effects were noted. Further
studies are needed to determine whether helium can
improve ventilation and oxygenation, and allow for lower
ventilating pressures in patients with more severe lung
disease or with higher concentrations of helium.
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